South Asia Mail The risk was most significant in patients taking atorvastatin (Lipitor), rosuvastatin (Crestor) and simvastatin (Zocor), according to the study, published in BMJ. Statins are the most widely prescribed medications for the prevention of cardiovascular ... and more »
Common Ground.ca Liptruzet is a combination of two different cholesterol-altering drugs: ezetimibe and atorvastatin . As I've pointed out in previous columns, the highest quality, systematic evidence available shows that most people who have high cholesterol won't ...
Cardiovascular Business AstraZeneca plans to file a supplemental NDA for Epanova as a treatment for patients with mixed dyslipidemia (triglyceride levels of 200-499mg/dl), as well as in a fixed dose combination with rosuvastatin calcium (Crestor, AstraZeneca) for mixed ...
DrugWatch.com The study authors determined that patients who take Lipitor ( atorvastatin ), Crestor (rosuvastatin) or Zocor (simvastatin) to manage or prevent high cholesterol face a higher risk for developing the disease compared with those taking Pravachol ...
StreetInsider.com (subscription) AstraZeneca aims to file a supplemental NDA as soon as possible for Epanova as a treatment for patients with mixed dyslipidemia (triglyceride levels of 200-499mg/dl), as well as in a fixed dose combination with CRESTOR ( rosuvastatin calcium) for those ... and more »
BioWorld Online ... launch Epanova in multiple markets," he said, affirming that the fixed-dose approach with Crestor is "a good life cycle management strategy for AstraZeneca," although "physicians may well prefer to use Epanova as an add-on to generic atorvastatin ... and more »
PhysBizTech “No such risk was evident with fluvastatin or lovastatin . The risk associated with rosuvastatin could depend on dose and duration of treatment. The risk of incident diabetes was similar whether statins were being used for primary or secondary ...
